Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update [Yahoo! Finance]
Biofrontera Inc. (BFRI)
Company Research
Source: Yahoo! Finance
WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three months ended March 31, 2024 and provided a business update. Highlights from the first quarter of 2024 and subsequent weeks included the following: Total revenues for the first quarter of 2024 were $7.9 million, a 9% decrease from the same period of the prior year primarily driven by reimbursement headwinds our customers experienced due to the Change Healthcare data breach Cash and cash equivalents were $3.8 million as of March 31, 2024, compared with $1.3 million on December 31, 2023 The Company completed a private placement of preferred stock with healthcare focused institutional investors for gross proceeds of $8 million Met operational and commercial milestones to secure an additional $8 million through the exercise of warrants in connection with
Show less
Read more
Impact Snapshot
Event Time:
BFRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BFRI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BFRI alerts
High impacting Biofrontera Inc. news events
Weekly update
A roundup of the hottest topics
BFRI
News
- Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp [Yahoo! Finance]Yahoo! Finance
- Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampGlobeNewswire
- $6.97 Billion Photodynamic Therapy Market Outlook, 2024-2032, Featuring Detailed Analysis of Gladerma, Sun Pharmaceutical Industries, Biofrontera, Lumibird, Bausch Health Companies, and More [Yahoo! Finance]Yahoo! Finance
- Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business UpdateAccesswire
- Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024Accesswire
BFRI
Earnings
- 5/15/24 - Miss
BFRI
Sec Filings
- 6/24/24 - Form 8-K
- 6/14/24 - Form 8-K
- 5/29/24 - Form SC
- BFRI's page on the SEC website